141 related articles for article (PubMed ID: 37783268)
1. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
[TBL] [Abstract][Full Text] [Related]
2. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
Derbel H; Krichen M; Chalaye J; Saccenti L; Van der Sterren W; Muris AH; Lerman L; Galletto A; Zaarour Y; Luciani A; Kobeiter H; Tacher V
Eur Radiol; 2023 May; 33(5):3510-3520. PubMed ID: 36651956
[TBL] [Abstract][Full Text] [Related]
4. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
6. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623
[TBL] [Abstract][Full Text] [Related]
8. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing
Noipinit N; Sukprakun C; Siricharoen P; Khamwan K
Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421
[TBL] [Abstract][Full Text] [Related]
9. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
[TBL] [Abstract][Full Text] [Related]
11.
Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
[TBL] [Abstract][Full Text] [Related]
12. Outpatient single-session yttrium-90 glass microsphere radioembolization.
Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Garin E; Lenoir L; Rolland Y; Edeline J; Mesbah H; Laffont S; Porée P; Clément B; Raoul JL; Boucher E
J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
[TBL] [Abstract][Full Text] [Related]
14. Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
Villalobos A; Cheng B; Wagstaff W; Sethi I; Bercu Z; Schuster DM; Brandon DC; Galt J; Kokabi N
J Vasc Interv Radiol; 2021 May; 32(5):752-760. PubMed ID: 33642158
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
16. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
[TBL] [Abstract][Full Text] [Related]
17. Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
Weissinger M; Vogel J; Kupferschläger J; Dittmann H; Castaneda Vega SG; Grosse U; Artzner C; Nikolaou K; la Fougere C; Grözinger G
PLoS One; 2020; 15(12):e0244235. PubMed ID: 33378338
[TBL] [Abstract][Full Text] [Related]
18. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.
Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G
Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338
[TBL] [Abstract][Full Text] [Related]
19. High quality imaging and dosimetry for yttrium-90 (
Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]